2019
DOI: 10.1002/ardp.201800382
|View full text |Cite
|
Sign up to set email alerts
|

Quinolone derivatives and their antifungal activities: An overview

Abstract: More than 300 million people suffer from the incidence of life‐threatening invasive fungal infections, resulting in over 1.35 million deaths annually. Currently, the antifungal agents available in clinics are rather limited, and the rapid development of resistance to the existing antifungal drugs has further aggravated mortality. Quinolones possess a broad spectrum of chemotherapeutic properties and demonstrate considerable antifungal activities as well. Various quinolone derivatives have been screened for the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(8 citation statements)
references
References 109 publications
(92 reference statements)
0
8
0
Order By: Relevance
“…There are numerous compounds in development that have been included in several recently published review articles [ 247 , 263 ]. The discovery of new potential drugs is in continuous progress.…”
Section: Compounds In Development Based On Antibacterial Qns Structuresmentioning
confidence: 99%
See 1 more Smart Citation
“…There are numerous compounds in development that have been included in several recently published review articles [ 247 , 263 ]. The discovery of new potential drugs is in continuous progress.…”
Section: Compounds In Development Based On Antibacterial Qns Structuresmentioning
confidence: 99%
“…This compound has been shown to be active against Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus agalactiae [ 268 ]. In a review article, Zhang Bo (2014) highlighted different series of QN derivatives with antifungal potential in terms of structure-activity relationship: 2-quinolone, 4-quinolone, and FQN derivatives and FQN-metal complexes [ 263 ]. Lapointe et al (2021) recently published the discovery and optimization of a novel series of compounds that inhibit the two bacterial target enzymes and stabilize the DNA cleavage complexes [ 269 ].…”
Section: Compounds In Development Based On Antibacterial Qns Structuresmentioning
confidence: 99%
“…Oral ciprofloxacin or intravenous injections are used for treatment of bone infections " [7]", febrile neutropenia, and anthrax " [8]", gastrointestinal infections " [9]", lower respiratory tract infections and pneumonia " [10]", chronic bacterial prostatitis and urinary tract infection " [11]", and complicated pyelonephritis in pediatrics " [12]". Various quinolone derivatives have been screened for their antifungal activities, and was seen exhibited potency against fungi " [13]". But they exhibit a low antiviral activity against SARS-CoV-2 and MERS-CoV " [14]".…”
Section: Clinical Indications For Ciprofloxacinmentioning
confidence: 99%
“…Ciprofloxacin, a yellowish crystalline substance, is a monohydrochloride monohydrate salt of 1cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo- [8]", anthrax " [9]", gastrointestinal infections " [10]", Lower respiratory tract infections " [11]", urinary tract infection " [12]", and complicated pyelonephritis " [13]". Various fluoroquinolone derivatives have been screened for their antifungal activities, and was seen exhibited potency against fungi " [14]", but they exhibit a low antiviral activity against SARS-CoV-2 and MERS-CoV " [15]". Ciprofloxacin is readily absorbed following oral administration, but the absolute bioavailability is within a range of 70-80% for the oral dose.…”
Section: Introductionmentioning
confidence: 99%